PhenoAge and PhenoAgeAccel in the context of dyslipidemia: association with stroke and potential as a new predictor in the US general population.

Weijie Zhao, Ziyue Wang, Chuanhao Mi, Yu Wang, Xinxin Shao, Xianghua Qi, Xinru Kong

Department of First Clinical Medical College, Shandong University of Traditional Chinese Medicine, No. 16369, Jingshi Road, Jinan, Shandong, 250014, China.Department of First Clinical Medical College, Shandong University of Traditional Chinese Medicine, No. 16369, Jingshi Road, Jinan, Shandong, 250014, China. · pubmed

Paper

Abstract

The challenges posed by an aging society are increasingly recognized, particularly regarding the potential impacts of high-fat diets and the trend toward younger ages of disease onset. The purpose of this study was to clarify the relationships between the prevalence of stroke in the general US population and PhenoAge (PA) and PhenoAgeAccel (PAA).

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper investigates the association between PhenoAge and PhenoAgeAccel with stroke prevalence in the context of dyslipidemia, which touches on aging-related metrics. However, it primarily focuses on the correlation with disease outcomes rather than addressing the root causes of aging or proposing interventions for lifespan extension. Thus, while it contributes to understanding aging-related diseases, its impact on the broader field of longevity research is limited.

Author of this paper? Send a correction.